Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Skin Cancer
50%
Squamous Cell Carcinoma
50%
Corticosteroid Therapy
50%
Sebaceous Cyst
50%
Early Intervention
50%
Ethosuximide
50%
Drug Megadose
50%
Indocyanine Green
50%
Nodular Melanoma
50%
Sentinel Node
50%
Proton Therapy
50%
Metastatic Carcinoma
50%
Melanoma
50%
Immunohistochemistry
37%
Neoplasm
37%
Baricitinib
28%
Percutaneous Aortic Valve Replacement
25%
Aortic Stenosis
25%
Subcutaneous Tissue
25%
Sigmoid
25%
Perineum
25%
General Anesthesia
25%
Retroperitoneal Lymph Node Dissection
25%
Biopsy
25%
Rehabilitation Engineering
25%
Sphincter
25%
Favre-Racouchot Syndrome
25%
Radical Resection
25%
Levator Ani Muscle
25%
Colostomy
25%
Bleeding
25%
Benign Tumor
25%
Clinician
25%
Carcinoma Cell
25%
Pigmented Lesion
21%
Lower Eyelid
21%
Lymphocyte Activation
16%
Arm
16%
Cheek
16%
Methylprednisolone
16%
Provocation Test
16%
Exanthem
16%
Benign Childhood Epilepsy
16%
Prednisone
16%
Corticosteroid
16%
Immunoglobulin
16%
Disease
16%
Papule
16%
Pulse Rate
16%
Nivolumab
14%
Keyphrases
Melanoma Cells
50%
Interleukin-23A
50%
Adhesion
50%
Advanced Malignant Melanoma
50%
EBI3
50%
T-5224
50%
Epidermal Cyst
50%
Malignant Melanoma
50%
Keratan Sulfate
50%
Sentinel Node Navigation Surgery
50%
Chronic Limb-threatening Ischemia
50%
Follicular Helper Cells
50%
Programmed Death-ligand 1 (PD-L1)
50%
Antigenicity
50%
Regulatory T (Treg) Cells
50%
LC-mass Spectrometry
50%
Indole Metabolites
50%
5-Methoxyindole-2-carboxylic Acid
50%
Preoperative Cardiac Evaluation
25%
Propeller Flap
25%
Baricitinib
22%
Paxillin
21%
Glycans
21%
Phosphorylation
21%
Early Therapy
16%
Viral Exanthem
16%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
15%
Liquid Chromatography-electrospray Tandem Mass Spectrometry
14%
Interleukin-39
14%
Invasiveness
14%
Proliferation-inducing Ligand
14%
V600K
12%
Solar Elastosis
12%
Lentiginous
12%
Intradermal Nevus
12%
Lateral Lymph Node Dissection
12%
Melanoma in Situ
12%
Team Collaboration
12%
Anti-cytotoxic
11%
Imiquimod
8%
MassARRAY System
8%
Analytical Evaluation
8%
Melanoma Biomarker
8%
Selective Reaction Monitoring
8%
Combination Therapy
7%
Monoclonal Antibody
7%
Cell Infiltration
7%
Acitretin
7%
Tildrakizumab
7%
Human Melanoma Cells
7%
Pharmacology, Toxicology and Pharmaceutical Science
Dermatitis
100%
Cytokine
86%
Tumor Necrosis Factor
66%
Psoriasis
64%
Serine Proteinase
50%
Dyslipidemia
50%
Melanoma
50%
Keratan Sulfate
50%
Cytotoxic T Lymphocyte Antigen 4
50%
Serine Peptidase Inhibitor Kazal Type 5
42%
5 Methoxyindole 2 Carboxylic Acid
37%
Glycan
35%
Leptin
33%
Palmitic Acid
33%
Baricitinib
28%
Proteinase
28%
Serine Proteinase Inhibitor
21%
Normal Human
21%
Paxillin
21%
Skin Disease
19%
Metabolic Disorder
16%
Inflammation
15%
Atopic Dermatitis
14%
Chymotrypsin
14%
Disease
14%
Chemokine
12%
APRIL Protein
12%
Phosphotransferase
8%
Imiquimod
8%
Mouse
8%
Disease Exacerbation
8%
Metabolic Syndrome X
8%
Biological Product
8%
Pheomelanin
7%
Enzyme-Linked Immunosorbent Assay
7%
Desquamation
7%
Skin Defect
7%
Proteoglycan
7%
Kallikrein
7%
Loricrin
7%
Filaggrin
7%
Peptidase
7%
Adaptor Protein
7%
Glycolipid
7%
Comorbidity
5%
Diseases
5%
